Joint Replacement
Conditions
Keywords
TEAS, complication
Brief summary
This is a single center, randomized, double-blinded, controlled clinical trial. The purpose of this study is to to determine whether treating by transcutaneous electrical acupoint stimulation (TEAS) during perioperative could alleviate the postoperative complications in patients undergoing artificial joint replacement surgery.
Detailed description
The complications from patients accepted artificial joint replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. It has been proved that the electroacupuncture application during perioperative period can reduce the dosage of anesthetic drugs, and has a good effect on the protection of the heart and brain. At the same time, the electroacupuncture can also regulate the body's immune function, reduce allergy, reduce postoperative pain and so on.Compared with acupuncture, transcutaneous electric acupoint stimulation (TEAS) is a noninvasive technique that has similar effects to acupuncture. The investigators hypothesize that TEAS before anesthesia and during surgery would decrease the morbidity and mortality of postoperative complications in 30 days after artificial joint replacement surgery.
Interventions
DEVICETEAS
Transcutaneous electrical acupoint stimulation
Sponsors
Second Hospital of Shanxi Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
60 Years to 89 Years
Healthy volunteers
No
Inclusion criteria
1. ASAⅡ-Ⅲ,elective operation patients 2. No other severe complications history 3. Able to give informed consent
Exclusion criteria
1. Having severe comorbidity resulting in estimated life expectancy \<1 year. 2. Infection at the electroacupuncture site. 3. Suffered from neurologic disorder or impaired mental state 4. Participate in the other clinical trial 3 months before the enrollment 5. No suitable to participate in this experiment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The incidence of postoperative complications | within 30 days after operation | Participants will be followed for the incidence of postoperative complications |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| length of postoperative hospital stay | an expected average of 1 week | Participants will be followed for the duration of hospital stay |
| Quality of life during 30 days after surgery | One month | evaluate the quality of life after surgery by WHO QOL-BREF scale with interview ，WHO QOL-BREF scale includes five aspects: physical, psychological, social, environmental, integrated, divided into five levels |
| ICU transfer rate after operation | One month | Participants will be followed for ICU transfer rate after operation |
Contacts
Primary ContactXiao-ying Zhao
Backup ContactZheng Guo
Outcome results
None listed